Tubulis GmbH’s Post

📢 𝗧𝘂𝗯𝘂𝗹𝗶𝘀 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 #𝗘𝗦𝗠𝗢𝟮𝟱! From October 17–21, our team will be in Berlin for this year’s ESMO Congress, ready to connect and share more about our differentiated #ADC pipeline. 📍 𝗪𝗵𝗲𝗿𝗲 𝘁𝗼 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘂𝘀 𝗢𝗿𝗮𝗹 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:  Don’t miss the oral late-breaking presentation on Sunday, October 19 (10:38–10:43 am) by Principal Investigator Antonio González Martín. He will share first clinical data from our Phase I/IIa NAPISTAR 1-01 study of TUB-040 in platinum-resistant ovarian cancer (#PROC) 𝗕𝗼𝗼𝘁𝗵 #𝟰𝟬𝟰𝟱:  Visit our booth in the northeast part of Hall 4.2 to learn more about our growing pipeline and proprietary technologies, which uniquely position us to unlock the full therapeutic potential of ADCs, transforming the cancer treatment landscape and delivering better outcomes for patients in need If you’re attending #ESMO25, reach out to Mary Ann Lumiqued to schedule a meeting at our booth and learn more about our differentiated approach to #ADCs.